Most Read Articles
11 Dec 2017
Combining the DASH (Dietary Approaches to Stop Hypertension) diet with low sodium intake reduces systolic blood pressure (SBP) in individuals with pre- and stage 1 hypertension, with progressively higher reductions at greater levels of baseline SBP, a recent study has shown.
Tristan Manalac, 4 days ago
Major depressive disorder (MDD) appears to be more prevalent in females than in males, particularly in those who are divorced or widowed, a recent study from Singapore has found.
6 days ago
Tadalafil may not be effective for reducing the decline in ambulatory ability in boys with Duchenne muscular dystrophy (DMD), as shown in a recent study.
01 Dec 2017
At a symposium during the 25th Congress of the Obstetrical and Gynaecological Society of Malaysia in Kuala Lumpur, Professor Susan Davis discussed the unique implications of women living decades beyond menopause, and how healthcare professionals can best manage menopausal symptoms in the short and long term.

Antipsychotic treatment ups risk of diabetes in schizophrenia

29 Jul 2017
The second generation injection may cost up to HK$5000 per month.

People with schizophrenia tend to have a high endogenous risk for diabetes, and both first- and second-generation antipsychotics further increase such risk, according to a study.

Researchers followed all individuals born in Denmark on or after 1 January 1977 until 1 January 2013 (n=2,736,510). Schizophrenia diagnoses were ascertained by the Danish Psychiatric Central Research Register. Data on prescriptions of antipsychotics were provided by the Danish National Prescription Registry, which along with the Danish National Patient Register ascertained diabetes.

Cox proportional hazards regression models, accounting for potential confounders, were used to estimate the endogenous and antipsychotic-related risks for diabetes.

A total of 14,118 cohort members (0.52 percent) developed diabetes, and 8.945 (0.33 percent) developed schizophrenia during follow-up (49,582,279 person-years).

Compared with the general population, those with antipsychotic-naïve schizophrenia had an adjusted hazard ratio (AHR) for diabetes of 3.07 (95 percent CI, 1.71 to 5.41). After adjustment for family history of diabetes and other potential confounders, the risk for diabetes after starting antipsychotic treatment was significantly higher (AHR, 3.64; 1.95 to 6.82) than the risk in antipsychotic-naïve schizophrenia.

The risk for diabetes increased with first-line treatment with either first- (AHR, 3.06; 1.32 to 7.05) or second-generation antipsychotics (AHR, 3.44; 1.73 to 6.83) without a statistically significant difference. These results were validated by appropriate sensitivity analyses limited to type 2 diabetes.

“Early detection and effective treatment of diabetes should be an integral part of multidisciplinary management of schizophrenia regardless of antipsychotic drug exposure,” researchers said, adding that diabetes mellitus contributes to excessive cardiovascular deaths and reduced life expectancy in schizophrenia.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
11 Dec 2017
Combining the DASH (Dietary Approaches to Stop Hypertension) diet with low sodium intake reduces systolic blood pressure (SBP) in individuals with pre- and stage 1 hypertension, with progressively higher reductions at greater levels of baseline SBP, a recent study has shown.
Tristan Manalac, 4 days ago
Major depressive disorder (MDD) appears to be more prevalent in females than in males, particularly in those who are divorced or widowed, a recent study from Singapore has found.
6 days ago
Tadalafil may not be effective for reducing the decline in ambulatory ability in boys with Duchenne muscular dystrophy (DMD), as shown in a recent study.
01 Dec 2017
At a symposium during the 25th Congress of the Obstetrical and Gynaecological Society of Malaysia in Kuala Lumpur, Professor Susan Davis discussed the unique implications of women living decades beyond menopause, and how healthcare professionals can best manage menopausal symptoms in the short and long term.